|
Real-time
Euronext Paris
10:27:12 02/10/26 pm AEST
|
5-day change | 1st Jan Change | ||
| 19.60 EUR | -1.26% |
|
0.00% | -35.31% |
| 18/09 | Boiron SA Reports Earnings Results for the Half Year Ended June 30, 2026 | CI |
| 23/04 | Boiron SA Reports Earnings Results for the Full Year Ended December 31, 2025 | CI |
| Market Cap | 345M 388M 322M 294M 553M 37.36B 561M 3.9B 1.51B 19.03B 1.46B 1.43B 61.11B | P/E 2024 |
41x | P/E 2025 | 16.1x |
|---|---|---|---|---|---|
| Enterprise Value | 297M 334M 278M 253M 476M 32.17B 483M 3.36B 1.3B 16.38B 1.25B 1.23B 52.63B | EV / Sales 2024 |
0.85x | EV / Sales 2025 | 0.95x |
| Free-Float |
19.96% | Yield 2024 |
4.48% | Yield 2025 | 4.46% |
Euronext ParisEUR
| Markets | Quality | ||
|---|---|---|---|
Euronext Paris
| BOI | Real-time | |
OTC Markets
| BOIRF | Delayed | |
CBOE
| BOIp | Real-time | |
Deutsche Boerse AG
| BON | Delayed | |
CBOE
| 0DTF | Real-time | |
Börse Stuttgart
| BON | Delayed | |
Boerse Muenchen
| BON | Real-time |
| 1 day | -1.26% | ||
| Current month | -2.00% | ||
| 1 month | -25.19% | ||
| 3 months | -28.99% | ||
| 6 months | -30.00% | ||
| Current year | -35.31% |
| 1 week | 19.3 | 20.9 | |
| 1 month | 19.3 | 26.7 | |
| Current year | 19.3 | 30.95 | |
| 1 year | 19.3 | 32.25 | |
| 3 years | 19.3 | 56.5 | |
| 5 years | 19.3 | 56.5 | |
| 10 years | 19.3 | 92.91 |
| Manager | Title | Age | Since |
|---|---|---|---|
Pascal Houdayer
CEO | Chief Executive Officer | 57 | 01/01/2025 |
Frédéric Riou
CTO | Chief Tech/Sci/R&D Officer | - | - |
Isabelle Chanel
CTO | Chief Tech/Sci/R&D Officer | - | 01/01/2022 |
| Director | Title | Age | Since |
|---|---|---|---|
Thierry Boiron
CHM | Chairman | 65 | 01/07/2011 |
| Director/Board Member | 54 | 10/03/2010 | |
| Director/Board Member | 51 | 23/05/2013 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 29/10/23 | Sell | Director | 198,664 | 1.1323% | ||
| 29/10/23 | Sell | Director | 462,964 | 2.6387% | ||
| 29/10/23 | Sell | Director | 4,748 | 0.0271% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -1.26% | 0.00% | -27.14% | -63.70% | 388M | ||
| -0.62% | -2.71% | +39.30% | +114.07% | 1,025B | ||
| -2.30% | -4.44% | +39.03% | +66.07% | 623B | ||
| -0.63% | -1.96% | +6.36% | +74.38% | 459B | ||
| -1.03% | -2.82% | +59.56% | +39.69% | 355B | ||
| -0.14% | -3.30% | +22.55% | +40.46% | 336B | ||
| -0.37% | -1.84% | +13.06% | +25.95% | 270B | ||
| +0.27% | -4.06% | -3.31% | +9.97% | 247B | ||
| -3.38% | +0.30% | +36.44% | +51.54% | 220B | ||
| -1.04% | -1.46% | +32.70% | +96.82% | 183B | ||
| Average | -0.28% | -1.63% | +21.86% | +45.53% | 371.86B | |
| Weighted average by Cap. | +0.16% | -2.11% | +30.37% | +69.50% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 488M 549M 456M 415M 782M 52.85B 793M 5.52B 2.14B 26.92B 2.06B 2.02B 86.45B | 501M 564M 469M 427M 804M 54.32B 815M 5.67B 2.19B 27.66B 2.12B 2.07B 88.86B |
| Net income | 11.34M 12.76M 10.6M 9.66M 18.19M 1.23B 18.44M 128M 49.65M 626M 47.92M 46.88M 2.01B | 32.64M 36.75M 30.53M 27.82M 52.37M 3.54B 53.09M 369M 143M 1.8B 138M 135M 5.79B |
| Net Debt | -49.74M -56M -46.51M -42.39M -79.8M -5.39B -80.9M -563M -218M -2.75B -210M -206M -8.82B | -47.86M -53.88M -44.75M -40.78M -76.78M -5.19B -77.83M -541M -210M -2.64B -202M -198M -8.49B |
Employees
2,623
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 02/10/26 | EUR 19.60 | -1.26% | 750 |
| 01/10/26 | EUR 19.85 | -0.75% | 5,359 |
| 30/09/26 | EUR 20.00 | 0.00% | 2,870 |
| 29/09/26 | EUR 20.00 | +0.25% | 2,684 |
| 28/09/26 | EUR 19.95 | +1.79% | 1,957 |
Annual profits - Rate of surprise
- Stock Market
- Stocks
- BOI Stock
Select your edition
All financial news and data tailored to specific country editions

















